Literature DB >> 8583215

CAG repeat expansion of Machado-Joseph disease in the Japanese: analysis of the repeat instability for parental transmission, and correlation with disease phenotype.

H Sasaki1, A Wakisaka, T Fukazawa, K Iwabuchi, T Hamada, A Takada, E Mukai, T Matsuura, T Yoshiki, K Tashiro.   

Abstract

Machado-Joseph disease (MJD) is caused by abnormal expansion of an unstable CAG repeat in a novel gene locating on chromosome 14q32.1. We analysed this CAG repeat polymorphism with 66 Japanese MJD patients. All the patients were selectively associated with abnormal expansion of the CAG repeat. Repeat length of the mutant allele did not overlap that of normal allele and closely correlated with not only age at onset but also with clinical phenotypes. CAG repeat size is apparently related to a wide variety of phenotypic presentations in MJD.

Entities:  

Mesh:

Year:  1995        PMID: 8583215     DOI: 10.1016/0022-510x(95)00175-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

2.  Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs.

Authors:  Jiaxin Hu; Keith T Gagnon; Jing Liu; Jonathan K Watts; Jeja Syeda-Nawaz; C Frank Bennett; Eric E Swayze; John Randolph; Jyoti Chattopadhyaya; David R Corey
Journal:  Biol Chem       Date:  2011-02-07       Impact factor: 3.915

Review 3.  The protective role of exercise against age-related neurodegeneration.

Authors:  Alyson Sujkowski; Luke Hong; R J Wessells; Sokol V Todi
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

Review 4.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

5.  ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.

Authors:  Jing Liu; Dongbo Yu; Yuichiro Aiba; Hannah Pendergraff; Eric E Swayze; Walt F Lima; Jiaxin Hu; Thazha P Prakash; David R Corey
Journal:  Nucleic Acids Res       Date:  2013-08-09       Impact factor: 16.971

6.  Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3.

Authors:  Sean L Johnson; Kozeta Libohova; Jessica R Blount; Alyson L Sujkowski; Matthew V Prifti; Wei-Ling Tsou; Sokol V Todi
Journal:  Neurobiol Dis       Date:  2021-09-24       Impact factor: 5.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.